Assessing predicted HIV-1 replicative capacity in a clinical setting.

Assessing predicted HIV-1 replicative capacity in a clinical setting.

HIV-1 replicative capacity (RC) provides a measure of within-host fitness and is determined in the context of phenotypic drug resistance testing. However it is unclear how these in-vitro measurements relate to in-vivo processes. Here we assess RCs in a clinical setting by combining a previously publ...

Full description

Bibliographic Details
Main Authors:	Roger D Kouyos, Viktor von Wyl, Trevor Hinkley, Christos J Petropoulos, Mojgan Haddad, Jeannette M Whitcomb, Jürg Böni, Sabine Yerly, Cristina Cellerai, Thomas Klimkait, Huldrych F Günthard, Sebastian Bonhoeffer, Swiss HIV Cohort Study
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-11-01
Series:	PLoS Pathogens
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22072960/pdf/?tool=EBI

Similar Items

Inferring epidemic contact structure from phylogenetic trees.
by: Gabriel E Leventhal, et al.
Published: (2012-01-01)

Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds.
by: Wan-Lin Yang, et al.
Published: (2015-03-01)

Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics.
by: Denise Kühnert, et al.
Published: (2018-02-01)

Exploring the complexity of the HIV-1 fitness landscape.
by: Roger D Kouyos, et al.
Published: (2012-01-01)

Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
by: Niko Beerenwinkel, et al.
Published: (2013-01-01)

Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase.
by: Rafal Mostowy, et al.
Published: (2012-01-01)

Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
by: Samuel Alizon, et al.
Published: (2010-09-01)

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.
by: Viktor von Wyl, et al.
Published: (2013-01-01)

Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup
by: Bachmann, Nadine, et al.
Published: (2017)

Recombination accelerates adaptation on a large-scale empirical fitness landscape in HIV-1.
by: Danesh Moradigaravand, et al.
Published: (2014-06-01)

Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup
by: Nadine Bachmann, et al.
Published: (2017-05-01)

Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
by: Teja Turk, et al.
Published: (2017-09-01)

Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1.
by: Luc Villandre, et al.
Published: (2016-01-01)

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

Detecting Selection in the HIV-1 Genome during Sexual Transmission Events
by: David Seifert, et al.
Published: (2022-02-01)

Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
by: Martinetti Gladys, et al.
Published: (2011-01-01)

Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link
by: Huyen Nguyen, et al.
Published: (2021-06-01)

Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
by: Pedram Sendi, et al.
Published: (2007-01-01)

An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters
by: Luisa Salazar-Vizcaya, et al.
Published: (2022-04-01)

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART
by: Chenjie Wan, et al.
Published: (2020-11-01)

Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.
by: Jörg Schüpbach, et al.
Published: (2013-01-01)

Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients
by: Katharina Kusejko, et al.
Published: (2022-07-01)

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART
by: Nadine Bachmann, et al.
Published: (2019-07-01)

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.
by: Viktor von Wyl, et al.
Published: (2011-01-01)

Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.
by: Katharina Kusejko, et al.
Published: (2020-12-01)

Phylodynamics on local sexual contact networks.
by: David A Rasmussen, et al.
Published: (2017-03-01)

Disentangling human tolerance and resistance against HIV.
by: Roland R Regoes, et al.
Published: (2014-09-01)

Minority K65R Variants and Early Failure of Antiretroviral Therapy in HIV-1–infected Eritrean Immigrant
by: Vineeta Bansal, et al.
Published: (2011-10-01)

Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study
by: Suraj Balakrishna, et al.
Published: (2021-10-01)

HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.
by: Olivier Gasser, et al.
Published: (2007-03-01)

The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study
by: Francesca Compagno, et al.
Published: (2019-04-01)

Emergence of Resistance to Integrase Strand Transfer Inhibitors during Dolutegravir Containing Triple-Therapy in a Treatment-Experienced Patient with Pre-Existing M184V/I Mutation
by: Dominique L. Braun, et al.
Published: (2020-11-01)

Unsupervised machine learning predicts future sexual behaviour and sexually transmitted infections among HIV-positive men who have sex with men.
by: Sara Andresen, et al.
Published: (2022-10-01)

Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
by: Delphine Sculier, et al.
Published: (2020-11-01)

Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy
by: Weber Rainer, et al.
Published: (2008-11-01)

Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis
by: Frédérique Hovaguimian, et al.
Published: (2021-02-01)

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
by: Tracy R Glass, et al.
Published: (2012-01-01)

Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.
by: Michael Huber, et al.
Published: (2006-11-01)

The Red Queen and the persistence of linkage-disequilibrium oscillations in finite and infinite populations
by: Bonhoeffer Sebastian, et al.
Published: (2007-11-01)